Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sunshine Biopharma (SBFM) Interest Coverage Ratio (2016 - 2024)

Sunshine Biopharma (SBFM) has disclosed Interest Coverage Ratio for 11 consecutive years, with 50.13 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Interest Coverage Ratio rose 227.13% year-over-year to 50.13, compared with a TTM value of 159.27 through Sep 2025, up 355.32%, and an annual FY2024 reading of 662.43, down 1800.74% over the prior year.
  • Interest Coverage Ratio was 50.13 for Q4 2024 at Sunshine Biopharma, up from 5176.64 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 50.13 in Q4 2024 and bottomed at 858990.0 in Q3 2022.
  • Average Interest Coverage Ratio over 5 years is 48088.2, with a median of 22.95 recorded in 2021.
  • The sharpest move saw Interest Coverage Ratio crashed 8109137.82% in 2022, then skyrocketed 227.13% in 2024.
  • Year by year, Interest Coverage Ratio stood at 3.26 in 2020, then crashed by 134.44% to 7.63 in 2021, then crashed by 11429.02% to 880.12 in 2022, then soared by 95.52% to 39.43 in 2023, then surged by 227.13% to 50.13 in 2024.
  • Business Quant data shows Interest Coverage Ratio for SBFM at 50.13 in Q4 2024, 5176.64 in Q2 2024, and 27.46 in Q1 2024.